...
首页> 外文期刊>American Journal of Pathology: Official Publication of the American Association of Pathologists >Interferon-gamma Released by Activated CD8 (+) T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves
【24h】

Interferon-gamma Released by Activated CD8 (+) T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves

机译:由活化的CD8(+)T淋巴细胞释放的干扰素-γ损害钙化人主动脉瓣膜骨壳的钙吸收电位

获取原文
获取原文并翻译 | 示例

摘要

In calcific aortic valve disease (CAVD), activated T lymphocytes localize with osteoclast regions; however, the functional consequences of this association remain unknown. We hypothesized that CD8(+) T cells modulate calcification in CAVD. CAVD valves (n = 52) dissected into noncalcified and calcified portions were subjected to mRNA extraction, real-time quantitative PCR, enzyme-linked immunosorbent assay, and immunohistochemical analyses. Compared with noncalcified portions, calcified regions exhibited elevated transcripts for CD8, interferon (IFN)-gamma, CXCL9, Perforin 1, Granzyme B, and heat shock protein 60. Osteoclast-associated receptor activator of NK-kappa B Ligand (RANKL), tartrate-resistant acid phosphatase (TRAP), and osteoclast-associated receptor increased significantly. The stimulation of tissue with phorbol-12-myristate-13-acetate and ionomycin, recapitulating CAVD microenvironment, resulted in IFN-gamma release. Real-time quantitative PCR detected mRNAs for CD8(+) T-cell activation (Perforin 1, Granzyme B). In stimulated versus unstimulated organoid cultures, elevated IFN-gamma reduced the mRNAs encoding for RANKL, TRAP, and Cathepsin K. Molecular imaging showed increased calcium signal intensity in stimulated versus unstimulated parts. CD14(+) monocytes treated either with recombinant human IFN-gamma or with conditioned media-derived IFN-gamma exhibited low levels of Cathepsin K, TRAP, RANK, and tumor necrosis factor receptor-associated factor 6 mRNAs, whereas concentrations of the T-cell co-activators CD80 and CD86 increased in parallel with reduced osteoclast resorptive function, effects abrogated by neutralizing anti-IFN-gamma antibodies. CD8(+) cell-derived IFN-gamma suppresses osteoclast function and may thus favor calcification in CAVD.
机译:在钙化主动脉瓣病(CAVD)中,活化的T淋巴细胞定位骨骨骨型区域;然而,这种关联的功能后果仍然是未知的。我们假设CD8(+)T细胞调节CAVD中的钙化。将静止阀(n = 52)分解成非钙化和钙化部分的MRNA提取,实时定量PCR,酶联免疫吸附测定和免疫组化分析。与非钙化部分相比,钙化区域表现出CD8,干扰素(IFN)-γ,CXCL9,PERFORIN 1,Granzzyme B和热休克蛋白60. NK-Kappa B配体(RANKL),酒石酸酯的骨质细胞相关受体活化剂的升高的转录物。 - 酸性酸性磷酸酶(捕集器)和疏口细胞相关受体显着增加。刺激与菲尔伯-12-豆蔻酸酯-13-乙酸盐和离子霉素的刺激,重新承载CAVD微环境,导致IFN-γ释放。实时定量PCR检测CD8(+)T细胞活化的MRNA(穿孔素1,颗粒酶B)。在刺激的与未暗示的有机体培养物中,升高的IFN-γ降低了对RankL,捕集器和组织蛋白酶K的MRNAS编码。分子成像显示出刺激的钙信号强度增加,而不是未刺激的部分。用重组人IFN-γ或用调节培养基衍生的IFN-gamma治疗的CD14(+)单核细胞表现出低水平的组织蛋白酶K,陷阱,等级和肿瘤坏死因子受体相关因子6mRNA,而T-的浓度细胞共激活剂CD80和CD86平行增加,随着破骨细胞复苏功能的降低,通过中和抗IFN-γ抗体效果。 CD8(+)细胞衍生的IFN-γ抑制破骨细胞功能,因此可以在CAVD中有利于钙化。

著录项

  • 来源
  • 作者单位

    Harvard Med Sch Brigham &

    Womens Hosp Dept Med Div Cardiovasc Med 77 Ave Louis Pasteur NRB 741;

    Harvard Med Sch Brigham &

    Womens Hosp Dept Med Div Cardiovasc Med 77 Ave Louis Pasteur NRB 741;

    Harvard Med Sch Brigham &

    Womens Hosp Dept Med Div Cardiovasc Med 77 Ave Louis Pasteur NRB 741;

    Brigham &

    Womens Hosp Ctr Perioperat Genom 75 Francis St Boston MA 02115 USA;

    Harvard Med Sch Brigham &

    Womens Hosp Dept Med Div Cardiovasc Med 77 Ave Louis Pasteur NRB 741;

    Harvard Med Sch Brigham &

    Womens Hosp Dept Med Div Cardiovasc Med 77 Ave Louis Pasteur NRB 741;

    Harvard Med Sch Brigham &

    Womens Hosp Dept Med Div Cardiovasc Med 77 Ave Louis Pasteur NRB 741;

    Beth Israel Deaconess Med Ctr Dept Surg Div Cardiac Surg 330 Brookline Ave Boston MA 02215 USA;

    Harvard Med Sch Brigham &

    Womens Hosp Dept Med Div Cardiovasc Med 77 Ave Louis Pasteur NRB 741;

    Karolinska Inst Dept Med Stockholm Sweden;

    Harvard Med Sch Brigham &

    Womens Hosp Dept Med Div Cardiovasc Med 77 Ave Louis Pasteur NRB 741;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号